In this between-subjects, placebo controlled, double-blind study, the investigators will examine the effects of low oral doses of nicotine on the learning and extinction of a conditioned place preference acquired in a virtual reality environment by healthy human subjects. Physiological and subjective responses to the drug will also be monitored.
External cues and contexts contribute to the development of smoking and the use of other drugs, and drugs themselves can alter the value of conditioned cues. Interestingly, nicotine increases the acquisition of new learning, and has been considered as a "cognitive enhancer". Nicotine also prolongs responding when responding is no longer rewarded, during extinction. Although many studies have examined the effects of drugs on learning (acquisition) and unlearning (extinction) in laboratory animals, few have investigated drug effects on learning in humans. Recently, novel procedures have been developed to study conditioning in humans, pairing initially neutral places with food, money or drugs. The investigators will use one of these procedures, a virtual place conditioning procedure, to study how nicotine affects the acquisition and extinction of conditioned behaviors in humans.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Participant receives oral dose of nicotine
Participant receives oral dose of placebo
University of Chicago Medical Center - Human Behavioral Pharmacology Lab
Chicago, Illinois, United States
Virtual Environment "Liking"
Time frame: Participant rate on a visual analog scale how much they prefer one virtual environment over another
Time spent in virtual environment
Time frame: Participants actively choose which environment to spend time in. The length of those virtual visits is measured and compared during the study sessions
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.